Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
IPO Date: July 18, 2013
Sector: Healthcare
Industry: Pharma
Market Cap: $1.49B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.91 | 2.06%
Avg Daily Range (30 D): $1.08 | 1.60%
Avg Daily Range (90 D): $0.92 | 1.49%
Institutional Daily Volume
Avg Daily Volume: .14M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .22M
Trade Size
Avg Trade Size (Sh.): 71
Avg Trade Size (Sh.) (30 D): 46
Avg Trade Size (Sh.) (90 D): 44
Institutional Trades
Total Inst.Trades: 1,954
Avg Inst. Trade: $1.83M
Avg Inst. Trade (30 D): $3.05M
Avg Inst. Trade (90 D): $2.71M
Avg Inst. Trade Volume: .03M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.09M
Avg Closing Trade (30 D): $3.43M
Avg Closing Trade (90 D): $3.13M
Avg Closing Volume: 37.01K
       
News
Feb 28, 2025 @ 3:37 PM
ANI Pharmaceuticals Expects Strong Start To 2025, ...
Source: Vandana Singh
Oct 30, 2024 @ 9:00 PM
ANI Pharmaceuticals to Discuss Third Quarter 2024 ...
Source: N/A
Oct 18, 2024 @ 6:38 PM
Avadel Obtains FDA Nod for Label Expansion Of Narc...
Source: Zacks
Oct 17, 2024 @ 5:44 PM
Alnylam Stock Up on Cardiomyopathy Drug Regulatory...
Source: Zacks
Sep 24, 2024 @ 7:08 PM
BHVN Stock Up as Rare Neurological Disease Study M...
Source: Zacks
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-1.04 $-.55 $-1.04
Diluted EPS $-1.04 $-.55 $-1.04
Revenue $ 614.38M $ 190.57M $ 614.38M
Gross Profit $ $ $
Net Income / Loss $ -18.52M $ -10.28M $ -18.52M
Operating Income / Loss $ .58M $ -4.38M $ .58M
Cost of Revenue $ $ $
Net Cash Flow $ -76.23M $ -.12M $ -76.23M
PE Ratio    
Splits
Jul 18, 2013:   6:1
Jun 04, 2012:   6:1
Jun 03, 2002:   10:1